In this work, we have generated human iPSC-based AGS disease models for RNASEH2B and TREX1 deficiencies that have allowed us to identify DNA damage as a major driver of proinflammatory responses in AGS astrocytes that lead to neurotoxicity, which we were able to prevent pharmacologically. This evidence concerns the gene RNASEH2B and Aicardi-Goutieres syndrome.